Le Lézard
Classified in: Health, Science and technology, Business
Subjects: ERN, CCA

SQI Diagnostics to Announce Third Quarter 2019 Results

TORONTO, Aug. 20, 2019 /CNW/ - SQI Diagnostics Inc. ("SQI Diagnostics" or the "Company") (TSX-V: SQD; OTCQB: SQIDF), today announced that it plans to release its financial and operational results for the three and nine months ended June 30, 2019, at 8:00 a.m. EDT Wednesday, August 28, 2019.  President and CEO, Andrew Morris, along with Company management, will host a conference call on Wednesday, August 28, 2019, at 10:00 a.m. EDT to review financial results and discuss business developments for the period. 

Conference Call Details:


Wednesday August 28, 2019


10:00 a.m. EDT

Live Call:

416 764 8609 (local) 1-888-390-0605 (Canada and the United States)

Conference ID:





An archived copy of the conference call will be available for 90 days on the Company website at www.sqidiagnostics.com/about/investors and also at https://event.on24.com/wcc/r/2073314/0A36EF745A92FEB8ADA0FF6CA750203B

Detailed financial statements and the management's discussion and analysis (MD&A) will also be made available on the Company website at www.sqidiagnostics.com and at www.sedar.com.

For more information, please contact:

Chief Executive Officer
Andrew Morris
416.674.9500 ext. 229

Vice President of Finance
Patricia Lie
416.674.9500 ext. 277

About SQI Diagnostics
SQI Diagnostics is a life sciences and diagnostics company that develops clinical grade multiplexed microarray and molecular assays run on its automated instrumentation for the pharmaceutical research, animal health, and clinical diagnostics markets. SQI develops custom research and diagnostic assays that are multiplexed; meaning the simplification, consolidation and automation of many individual tests into one. This increases sample throughput, reduces time, cost and chance for human error, and provides excellent data quality. For more information, please visit sqidiagnostics.com.

Forward-looking Statements
This press release contains certain words and statements, which may constitute "forward-looking statements" within the meaning of applicable securities laws.  Such statements reflect the current views of the Company with respect to future events and are subject to certain risks and uncertainties detailed in the Company's ongoing filings with the securities regulatory authorities, available to the public at www.sedar.com.  Actual results, events, and performance may differ materially. Readers are cautioned not to place undue reliance on these forward-looking statements. The Company undertakes no obligation to publicly update or revise any forward-looking statements either as a result of new information, future events or otherwise, except as required by applicable securities laws.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

SOURCE SQI Diagnostics Inc.

These press releases may also interest you

at 15:39
With the diabetes community at greater risk for complications during the COVID-19 pandemic, the American Diabetes Association® (ADA) and Sun Life partnered to reinvent this year's annual Call to Congress to educate advocates on COVID-19 and diabetes,...

at 15:32
Encore Life, the only practitioner-exclusive professional grade Hemp supplement manufacturer, and WholeScripts, powered by XYMOGEN, the fastest growing supplier of nutritional supplements, have signed a partnership agreement naming Encore Life as the...

at 15:32
A few weeks ago, the Institute for Research in Immunology and Cancer (IRIC) of the Université de Montréal launched an Emergency Fund in response to the health crisis created by the pandemic, in order to support research efforts to fight cancer and,...

at 15:30
Berkshire Sterile Manufacturing (BSM) located in Lee, MA has secured $16.5 million in financing from Berkshire Bank and Lee Bank to expand its operations in Lee. This financing will be used to add manufacturing capabilities including an additional...

at 15:25
Thomson Rogers has issued a class action proceeding claiming $20 million dollars in damages on behalf of residents of Altamont Community Care (Altamont) and their families on June 1st, 2020. Altamont is a long-term care home owned by Sienna Senior...

at 15:18
As the number of patients who require care for COVID-19 across the state of Michigan decreases and restrictions put in place by the Governor are lifted, Karmanos Cancer Institute continues to offer all cancer care services....

News published on 20 august 2019 at 14:37 and distributed by: